KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $2.3 billion.

  • West Pharmaceutical Services' Non-Current Assets rose 743.7% to $2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 billion, marking a year-over-year increase of 1118.06%. This contributed to the annual value of $2.1 billion for FY2024, which is 1120.91% up from last year.
  • Latest data reveals that West Pharmaceutical Services reported Non-Current Assets of $2.3 billion as of Q3 2025, which was up 743.7% from $2.3 billion recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Non-Current Assets registered a high of $2.3 billion during Q3 2025, and its lowest value of $1.4 billion during Q1 2021.
  • Its 5-year average for Non-Current Assets is $1.8 billion, with a median of $1.8 billion in 2023.
  • As far as peak fluctuations go, West Pharmaceutical Services' Non-Current Assets soared by 251.89% in 2022, and later skyrocketed by 1919.32% in 2024.
  • West Pharmaceutical Services' Non-Current Assets (Quarter) stood at $1.6 billion in 2021, then rose by 7.98% to $1.7 billion in 2022, then grew by 11.54% to $1.9 billion in 2023, then grew by 11.21% to $2.1 billion in 2024, then grew by 8.42% to $2.3 billion in 2025.
  • Its Non-Current Assets stands at $2.3 billion for Q3 2025, versus $2.3 billion for Q2 2025 and $2.2 billion for Q1 2025.